Idiopathic Generalized Epilepsy Syndromes

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Apr 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a group of epilepsy disorders known as idiopathic generalized epilepsies (IGEs), which include conditions like childhood absence epilepsy and juvenile myoclonic epilepsy. The goal of the trial is to understand the characteristics of these syndromes better, including how they show up in brain scans and their long-term outcomes. By gathering detailed information from patients, the researchers hope to improve how these epilepsy types are diagnosed and treated, helping doctors choose the right medications and providing better guidance to patients about their condition.

To participate in this trial, individuals should be between 1 and 16 years old and have either a new or established diagnosis of idiopathic generalized epilepsy based on the latest guidelines from 2022. Participants will undergo a thorough assessment that includes a 24-hour video and brain wave recording, which helps doctors see how epilepsy affects them over time. It's important to note that participants will need to provide consent to be part of the study, and the trial is currently recruiting patients from epilepsy centers. If a participant develops a different kind of epilepsy during the study, they may be excluded from further participation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients are consecutively and prospectively enrolled from epilepsy center, with newly diagnosed epilepsy or established epilepsy.
• • Patients have a diagnosis of idiopathic generalized epilepsy (IGE), according to the 2022 diagnostic criteria.
• • Comprehensive clinical information is collected, and 24 hour video-electroencephalography is performed.
• • Sign the informed consent forms.
• Exclusion Criteria:
• • Other epilepsy syndromes are considered during follow-up, such as genetic generalized epilepsy.
• • Lost to follow-up